Work

Chemoradiotherapy Combined with Nab-Paclitaxel plus Cisplatin in Patients with Locally Advanced Borderline Resectable or Unresectable Esophageal Squamous Cell Carcinoma: A Phase I/II Study

Year: 2023

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2023.06.2433

Authors: N. Yu, J. Li, X. Chen, Z. Wang, X. Kang, R. Zhang, J. Qin, Q. Zheng, G. Feng, L. Deng, T. Zhang, W. Wang, W. Liu, J. Wang, Q. Feng, J. Lv, D. Chen, Z. Zhou, Z. Xiao, Y. Li, N. Bi, Y. Li, X. Wang

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences

Language: English

Topic: Esophageal Cancer Research and Treatment

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4387207214

FWCI:

Cites:

Cited by:

Related to: 10